Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 70 | 0 | 0 | 0 | 0 |
| Gross Profit | 70 | N/A | N/A | N/A | N/A |
| Operating Expenses | 56 | 6,322 | 264 | 4,526 | 595 |
| Operating Income | 15 | -6,322 | -264 | -4,526 | -595 |
| Interest Expense | 185 | 257 | 394 | 972 | 607 |
| Other Income | 212 | -271 | 52 | 153 | 343 |
| Pre-tax Income | 41 | -6,850 | -606 | -5,344 | -859 |
| Net Income Continuous | 41 | -6,850 | -606 | -5,344 | -859 |
| Minority Interests | -74 | -93 | -81 | -55 | -82 |
| Net Income | $115 | $-6,757 | $-525 | $-5,289 | $-778 |
| EPS Basic Total Ops | 0.00 | -0.02 | 0.00 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.02 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.02 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | 0.00 | -0.02 | 0.00 |
| EBITDA(a) | $-237 | $-153 | $-98 | $1 | $-169 |